Coronary Artery Disease in Patients With Friedreich's Ataxia

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

August 1, 2023

Study Completion Date

September 1, 2023

Conditions
Friedreich Ataxia
Interventions
DIAGNOSTIC_TEST

plethysmography

"Forearm blood flow (FBF) measurements in both arms will be made using venous occlusion strain-gauge plethysmography prior to the initiation of any intra-arterial infusions. All FBF measurements will be expressed as mL/min per 100-1 mL forearm volume according to prior studies and the Whitney method.1, 2 Resting baseline FBF will be measured at least 30 minutes after venous and arterial catheter placement to ensure that blood flows in the cannulated arms are stabilized. We will measure FBF during the last 2 minutes of each infusion period. Infusions of individual vasoactive medications will occur over a 15-minute interval. There will be a 25-minute washout between vasoactive medications. Cumulative dose response curves will be constructed over 5-minute incremental infusions. We will proceed in the following order:~* SNP 0.8, 1.6 and 3.2 mcg/min~* ACh 7.5, 15 and 30 mcg/min~* Normal saline"

Trial Locations (1)

15213

Montefiore Hospital Clinical and Translational Research Center, Pittsburgh

All Listed Sponsors
collaborator

Friedreich's Ataxia Research Alliance

OTHER

lead

University of Pittsburgh

OTHER

NCT04649866 - Coronary Artery Disease in Patients With Friedreich's Ataxia | Biotech Hunter | Biotech Hunter